Flick Intelligence v. HP: Auto-Focus Lens Patent Dismissed With Prejudice in 97 Days
Flick Intelligence, LLC asserted US9465237B2 — covering automatic focus prescription lens eyeglasses — against Hewlett-Packard in the Eastern District of Texas before Judge Rodney Gilstrap. The parties jointly stipulated to dismissal with prejudice in just 97 days, with each side bearing its own costs and attorneys’ fees.
Early Joint Dismissal Signals Rapid Resolution in E.D. Texas Auto-Focus Lens Dispute
On June 26, 2025, Flick Intelligence, LLC filed a patent infringement action against Hewlett-Packard Co. in the U.S. District Court for the Eastern District of Texas (Case No. 2:25-cv-00663), assigned to Judge Rodney Gilstrap. The asserted patent, US9465237B2 (application no. US14/142591), covers automatic focus prescription lens eyeglasses — a technology with relevance to wearable computing and augmented-reality-adjacent optical hardware. HP was the sole defendant, represented by counsel from Gillam & Smith, LLP and Shelton Coburn LLP.
The case closed on October 1, 2025 — just 97 days after filing — via a joint stipulation and motion of dismissal filed by both parties. Judge Gilstrap granted the motion, dismissing all of Flick Intelligence’s claims against HP with prejudice. Critically, the order specified that the parties bear their own costs and attorneys’ fees, meaning no economic penalty was imposed on either side beyond their own litigation spend. A with-prejudice dismissal permanently extinguishes Flick Intelligence’s right to reassert the same claims against HP on US9465237B2.
A 97-day resolution is notably rapid for a patent case in the Eastern District of Texas, where cases routinely extend well beyond a year. The speed and the mutual cost-bearing terms are consistent with a confidential settlement or licensing arrangement reached shortly after filing, though the public record does not confirm any such agreement. What drove the parties to this outcome — whether claim weakness, commercial agreement, or litigation economics — remains undisclosed.
Filing to Dismissed with Prejudice in 97 days
97 days — well below the E.D. Texas median for patent cases, suggesting early resolution
Dismissed with prejudice: what the joint stipulation means for both parties
Joint stipulation dismissal with prejudice explained
A dismissal with prejudice under a joint stipulation means both parties agreed to end the case and the court accepted. ‘With prejudice’ is the critical qualifier: it operates as a final adjudication on the merits, permanently barring Flick Intelligence from bringing the same patent claims against HP in any future action. This is a stronger form of closure than a without-prejudice dismissal, which would leave the door open to re-filing.
Rule 41(a)(1)(A)(ii) mechanismFlick Intelligence gives up all future claims against HP on this patent
By agreeing to a with-prejudice dismissal, Flick Intelligence permanently relinquishes its ability to sue HP again on US9465237B2. This is a significant concession. The mutual cost-bearing terms suggest neither party extracted a public financial victory. However, the speed of resolution — 97 days — is consistent with a private commercial resolution, which the public record does not confirm or deny.
Claims extinguished against HPHP secures permanent shield from this specific patent claim
HP emerges from this case with a with-prejudice dismissal on the record — effectively a permanent bar against Flick Intelligence re-asserting US9465237B2 against it. HP’s counsel team from Gillam & Smith and Shelton Coburn LLP resolved the matter before any substantive rulings on validity or infringement, preserving optionality and avoiding judicial scrutiny of the patent’s claims. Each party bearing its own fees suggests a negotiated exit.
Permanent bar on re-filingPatent survives — risk remains for other auto-focus optics players
Crucially, US9465237B2 was not invalidated. The patent remains in force and can still be asserted against other companies in the automatic focus prescription lens and wearable optics space. The lack of any validity or infringement ruling means competitors in smart eyewear, AR headsets, or adaptive lens hardware cannot rely on this case as prior art-based protection. A new FTO analysis against US9465237B2 is warranted for any player commercialising related technology.
Patent still live and assertableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Flick Intelligence, LLC | Company | Patent assertion entity — holder of US9465237B2, auto-focus prescription lens eyeglassesSearch in Eureka ↗ |
| Defendant | Hewlett-Parkard, Co. | Company | Hewlett-Packard Co. — global technology hardware and computing products companySearch in Eureka ↗ |
| Plaintiff counsel | William P. Ramey , III | Attorney | Counsel for Flick Intelligence, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Ramey LLP | Law Firm | Representing Flick Intelligence, LLCSearch in Eureka ↗ |
| Defendant counsel | Barry Kenneth Shelton | Attorney | Counsel for Hewlett-Parkard, Co.Search in Eureka ↗ |
| Defendant counsel | Bradley Dalton Coburn | Attorney | Counsel for Hewlett-Parkard, Co.Search in Eureka ↗ |
| Defendant counsel | Melissa Richards Smith | Attorney | Counsel for Hewlett-Parkard, Co.Search in Eureka ↗ |
| Defendant law firm | Gillam & Smith, LLP | Law Firm | Representing Hewlett-Parkard, Co.Search in Eureka ↗ |
| Defendant law firm | Shelton Coburn LLP | Law Firm | Representing Hewlett-Parkard, Co.Search in Eureka ↗ |
| Presiding judge | Judge Rodney Gilstrap | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The dismissal order confirms a jointly stipulated exit with no judicial finding on infringement or validity. The with-prejudice qualifier is legally significant: it forecloses any future re-assertion of the same claims by Flick Intelligence against HP, functioning as a final disposition on the merits for preclusion purposes. The mutual cost-bearing instruction signals a negotiated resolution rather than a capitulation by either side. No claim construction, summary judgment, or damages ruling was issued, leaving the technical scope of US9465237B2 judicially unexamined.
US9465237B2 — Automatic Focus Prescription Lens Eyeglasses
US9465237B2, filed under application number US14/142591, covers automatic focus prescription lens eyeglasses — technology that enables lenses to dynamically adjust focus without manual intervention by the wearer. This places the patent at the intersection of adaptive optics, wearable computing hardware, and corrective vision technology. The patent’s claims are likely directed to the mechanisms by which focus adjustment is detected, triggered, or mechanically or electronically executed within a spectacle-form-factor device.
The commercial relevance of US9465237B2 extends beyond traditional corrective eyewear into the emerging smart glasses and AR/VR headset markets, where auto-focus and adaptive lens functionality are increasingly integrated into consumer and enterprise hardware. Any OEM or component supplier working on electronically adjustable lenses, liquid lens technology, or gaze-tracking optical systems should treat this patent as a potential enforcement vector. The absence of any invalidity ruling from this case means the patent’s claims have not been narrowed or cancelled.
Should your team run an FTO analysis against US9465237B2?
If your organisation is developing or commercialising automatic focus eyewear, adaptive prescription lenses, smart glasses, AR headsets, or any wearable device incorporating electronically adjustable optical elements, US9465237B2 warrants direct FTO scrutiny. The patent has demonstrated assertability — it was filed in the Eastern District of Texas, one of the most plaintiff-friendly venues — and it emerged from this case without any adverse validity ruling. Hardware OEMs, lens manufacturers, and wearable tech companies should not assume the HP dismissal provides any freedom to operate.
PatSnap Eureka’s FTO Search Agent can map your product’s technical features against the claim scope of US9465237B2, identify prior art that could support an IPR petition, surface related continuations or divisionals in the US14/142591 family, and flag jurisdictions where the patent family holds granted rights. For companies in the adaptive optics or wearable lens space, proactive FTO analysis is materially lower-cost than reactive litigation defence in E.D. Texas.
Run a freedom-to-operate analysis on US9465237B2 to assess your product’s exposure
Run FTO in Eureka →Similar Adaptive Optics & Wearable Lens Patent Cases in E.D. Texas
Explore patent assertion cases involving adaptive optics, wearable eyewear, and auto-focus lens technology filed in the Eastern District of Texas before Judge Gilstrap.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Automatic focus prescription lens eyeglasses-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedFlick Intelligence, LLC’s broader IP enforcement history
Flick Intelligence, LLC’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the adaptive optics and wearable lens IP landscape
A rapid with-prejudice exit in E.D. Texas without validity rulings keeps US9465237B2 fully armed for future assertion campaigns.
No invalidity ruling means the patent retains full enforcement potential
Because the case was dismissed on joint stipulation before any claim construction or validity ruling, US9465237B2 emerges legally intact. Companies in the adaptive lens, smart eyewear, or AR optics sectors cannot treat this outcome as any form of validity shield. The patent remains a live enforcement risk for the entire technology category.
97-day resolution in E.D. Texas signals early commercial engagement
Patent cases before Judge Gilstrap in the Eastern District of Texas rarely resolve this quickly through purely procedural means. A 97-day with-prejudice dismissal bearing its own costs is strongly consistent with a licensing agreement or other private commercial resolution reached shortly after filing, though this is unconfirmed from the public record.
Ramey LLP’s filing history suggests a broader assertion strategy worth mapping
Flick Intelligence is represented by Ramey LLP, a firm with a documented history of high-volume patent assertion in E.D. Texas. Monitoring Ramey LLP’s filing activity against other technology companies on US9465237B2 or related application family members is a prudent risk-management step for companies in the wearable optics space.
Application family of US14/142591 may contain continuation risk for hardware OEMs
The asserted patent traces to application US14/142591. Patent families commonly include continuations or divisionals that can be crafted to cover adjacent product configurations. OEMs producing AR headsets, smart glasses, or electronically adjustable lens products should audit the full family of US14/142591 for pending or issued continuation claims that could support future assertions.
Flick v Hewlett-Parkard — key questions answered
The with-prejudice dismissal permanently bars Flick Intelligence from reasserting the same patent claims under US9465237B2 against HP in any future action. It functions as a final adjudication on the merits for claim preclusion purposes. However, it does not invalidate the patent, which remains enforceable against other parties.
No. The case was dismissed by joint stipulation before any substantive ruling on infringement or validity. Judge Gilstrap’s order did not address the merits of the patent claims. US9465237B2 remains a fully valid, issued U.S. patent that can be asserted against other defendants.
A 97-day resolution via joint stipulation in the Eastern District of Texas is significantly faster than the median patent case lifespan in that court. The speed, combined with a mutual cost-bearing order, is consistent with an early-stage private commercial resolution such as a licensing agreement. The public record does not confirm any specific terms beyond the dismissal itself.
US9465237B2 covers automatic focus prescription lens eyeglasses — devices in which the lens focus adjusts dynamically without manual input. This technology is relevant to smart eyewear, augmented reality headsets, and adaptive vision correction products. As AR and wearable computing hardware grows, the patent’s claim scope may intersect with electronically adjustable lens and gaze-tracking optical systems.
No. The dismissal provides no FTO protection for third parties. Because the case ended without any invalidity or non-infringement ruling, other companies in the adaptive lens or wearable optics sector cannot rely on this outcome as a legal defence. Each company’s exposure to US9465237B2 must be assessed independently through its own FTO analysis.
Monitor US9465237B2 and the Auto-Focus Lens IP Landscape with PatSnap
US9465237B2 survived this case without an invalidity ruling and can still be asserted. Set up patent family monitoring and run an FTO analysis in PatSnap Eureka to stay ahead of enforcement risk in adaptive optics and wearable eyewear.
PatSnap Eureka searches patents and litigation data to answer instantly.